Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Agonists on Cardiac Steatosis in Type 2 Diabetes (LICAS-MR)
NCT03498001Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Apr 2018
- Primary completion
- Jun 2023
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Open-label trial of liraglutide, semaglutide and dulaglutide in type 2 diabetes mellitus (T2DM), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Apr 2018; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03498001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03498001.